BibTex RIS Cite

Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report

Year 2011, Volume: 4 Issue: 2, 70 - 73, 01.06.2011

Joslei Carlos Bohn Lucimari Teixeira Cassiano Lima Chaiben Adriano Kuczynski Francisca Berenice Dias Gil Antonio Adilson Soares De Lima

Abstract

Keywords

-

References

  • Neville B, Damm DD, Allen CM, Bouqout J, eds. Viral infections. In: Oral and Maxillofacial Pathology. 2nd ed. St. Louis: Saunders; 2002: 213-252.
  • Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993; 118(4): 268-72.
  • Miller CS, Danaher RJ, Jacob RJ. Molecular Aspects of Herpes Simplex Virus I Latency, Reactivation, and Recurrence. Crit Rev Oral Biol Med. 1998 9: 541-562.
  • Habif TP. Herpes simplex. In: Baxter S, ed. Clinical dermatology: a color guide to diagnosis and therapy. 3rd ed. St. Louis. Mosby-Year Book, 1996: 325-44.
  • Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia. Churchill Livingstone, 1998: 1564-80.
  • Brown RS, Eiland D. Palatal lesions in an otherwise healthy patient. J Am Dent Assoc. 2010; 141(4): 429-32.
  • He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, Gabrio J, Rui BL, Zhang ZF, Fu ZH, Ding YY, Zhao GM, Jiang QW, Detels R. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011; 5(1): 1-9.
  • Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011; 23(1): 130-6.
  • Langley RG. Famciclovir for the treatment of recurrent genital and labial herpes lesions. Skin Therapy Lett. 2005; 10(10): 5-7.
  • Schubert MM. Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent. 1991; 1(4): 384- 97.
  • Whitley RJ, Roizman B: Herpes simplex virus infections. Lancet 2001; 357:1513–1518.
  • Ozcan A, Senol M, Saglam H, Seyhan M, Durmaz R, Aktas E, Ozerol IH: Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol 2007; 46:1177–1179.
  • Duggal MS, Abudiak H, Dunn C, Tong HJ, Munyombwe T. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS. Eur Arch Paediatr Dent. 2010; 11(5): 242-6.
  • Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008; 168(11): 1137-44.
  • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment http://www.cdc.gov/std/treatment/2010/genital-ulcers.htm#hsv. Accessed June 2, 2011. 2010. Available at:
  • Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, et al. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA. 1988; 260: 2227-30.
  • Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA. 1991; 265: 747-51.

Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report

Year 2011, Volume: 4 Issue: 2, 70 - 73, 01.06.2011

Joslei Carlos Bohn Lucimari Teixeira Cassiano Lima Chaiben Adriano Kuczynski Francisca Berenice Dias Gil Antonio Adilson Soares De Lima

Abstract

Keywords

-

References

  • Neville B, Damm DD, Allen CM, Bouqout J, eds. Viral infections. In: Oral and Maxillofacial Pathology. 2nd ed. St. Louis: Saunders; 2002: 213-252.
  • Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993; 118(4): 268-72.
  • Miller CS, Danaher RJ, Jacob RJ. Molecular Aspects of Herpes Simplex Virus I Latency, Reactivation, and Recurrence. Crit Rev Oral Biol Med. 1998 9: 541-562.
  • Habif TP. Herpes simplex. In: Baxter S, ed. Clinical dermatology: a color guide to diagnosis and therapy. 3rd ed. St. Louis. Mosby-Year Book, 1996: 325-44.
  • Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia. Churchill Livingstone, 1998: 1564-80.
  • Brown RS, Eiland D. Palatal lesions in an otherwise healthy patient. J Am Dent Assoc. 2010; 141(4): 429-32.
  • He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, Gabrio J, Rui BL, Zhang ZF, Fu ZH, Ding YY, Zhao GM, Jiang QW, Detels R. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011; 5(1): 1-9.
  • Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011; 23(1): 130-6.
  • Langley RG. Famciclovir for the treatment of recurrent genital and labial herpes lesions. Skin Therapy Lett. 2005; 10(10): 5-7.
  • Schubert MM. Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent. 1991; 1(4): 384- 97.
  • Whitley RJ, Roizman B: Herpes simplex virus infections. Lancet 2001; 357:1513–1518.
  • Ozcan A, Senol M, Saglam H, Seyhan M, Durmaz R, Aktas E, Ozerol IH: Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol 2007; 46:1177–1179.
  • Duggal MS, Abudiak H, Dunn C, Tong HJ, Munyombwe T. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS. Eur Arch Paediatr Dent. 2010; 11(5): 242-6.
  • Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008; 168(11): 1137-44.
  • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment http://www.cdc.gov/std/treatment/2010/genital-ulcers.htm#hsv. Accessed June 2, 2011. 2010. Available at:
  • Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, et al. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA. 1988; 260: 2227-30.
  • Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA. 1991; 265: 747-51.
There are 17 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Joslei Carlos Bohn This is me

Lucimari Teixeira This is me

Cassiano Lima Chaiben This is me

Adriano Kuczynski This is me

Francisca Berenice Dias Gil This is me

Antonio Adilson Soares De Lima This is me

Publication Date June 1, 2011
Published in Issue Year 2011 Volume: 4 Issue: 2

Cite

APA Bohn, J. C., Teixeira, L., Chaiben, C. L., Kuczynski, A., et al. (2011). Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report. Journal Of International Dental And Medical Research, 4(2), 70-73.
AMA Bohn JC, Teixeira L, Chaiben CL, Kuczynski A, Gil FBD, Lima AASD. Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report. JIDMR. June 2011;4(2):70-73.
Chicago Bohn, Joslei Carlos, Lucimari Teixeira, Cassiano Lima Chaiben, Adriano Kuczynski, Francisca Berenice Dias Gil, and Antonio Adilson Soares De Lima. “Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report”. Journal Of International Dental And Medical Research 4, no. 2 (June 2011): 70-73.
EndNote Bohn JC, Teixeira L, Chaiben CL, Kuczynski A, Gil FBD, Lima AASD (June 1, 2011) Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report. Journal Of International Dental And Medical Research 4 2 70–73.
IEEE J. C. Bohn, L. Teixeira, C. L. Chaiben, A. Kuczynski, F. B. D. Gil, and A. A. S. D. Lima, “Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report”, JIDMR, vol. 4, no. 2, pp. 70–73, 2011.
ISNAD Bohn, Joslei Carlos et al. “Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report”. Journal Of International Dental And Medical Research 4/2 (June 2011), 70-73.
JAMA Bohn JC, Teixeira L, Chaiben CL, Kuczynski A, Gil FBD, Lima AASD. Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report. JIDMR. 2011;4:70–73.
MLA Bohn, Joslei Carlos et al. “Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report”. Journal Of International Dental And Medical Research, vol. 4, no. 2, 2011, pp. 70-73.
Vancouver Bohn JC, Teixeira L, Chaiben CL, Kuczynski A, Gil FBD, Lima AASD. Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report. JIDMR. 2011;4(2):70-3.